俞 江,郑 甲,陈建州,康丽娜,张荣林.血清CysC、CT-1联合FFR值预测冠状动脉中度狭窄冠心病患者PCI术后主要心脏不良事件发生风险的临床研究[J].现代生物医学进展英文版,2024,(7):1306-1311. |
血清CysC、CT-1联合FFR值预测冠状动脉中度狭窄冠心病患者PCI术后主要心脏不良事件发生风险的临床研究 |
Clinical Study on Serum CysC, CT-1 Combined with FFR Value in Predicting the Risk of Major Adverse Cardiac Events after PCI in Patients with Coronary Heart Disease with Moderate Coronary Artery Stenosis |
Received:September 03, 2023 Revised:September 25, 2023 |
DOI:10.13241/j.cnki.pmb.2024.07.020 |
中文关键词: 冠状动脉中度狭窄 经皮冠状动脉介入治疗 CysC CT-1 FFR 主要心脏不良事件 |
英文关键词: Moderate coronary artery stenosis Percutaneous coronary intervention CysC CT-1 FFR Major adverse cardiac events |
基金项目:江苏省第五期"333工程"培养资金资助项目(BRA2017268) |
|
Hits: 289 |
Download times: 201 |
中文摘要: |
摘要 目的:探讨血清胱抑素C(CysC)、心肌营养素-1(CT-1)联合冠状动脉血流储备分数(FFR)值预测冠状动脉中度狭窄冠心病患者经皮冠状动脉介入治疗(PCI)术后主要心脏不良事件(MACE)发生风险的预测价值。方法:选取2020年1月~2022年3月南京鼓楼医院收治的冠状动脉中度狭窄冠心病患者260例,根据PCI术后1年是否发生MACE分为MACE组36例和非MACE组224例。检测血清CysC、CT-1水平和计算FFR值。构建多因素Logistic回归模型分析影响冠状动脉中度狭窄冠心病患者PCI术后MACE发生的风险因素,绘制受试者工作特征(ROC)曲线分析血清CysC、CT-1联合FFR值对冠状动脉中度狭窄冠心病患者PCI术后MACE发生风险的预测价值。结果:随访1年,无失访病例,260例冠状动脉中度狭窄冠心病患者PCI术后MACE发生率为13.85%(36/260)。与非MACE组比较,MACE组血清CysC、CT-1水平升高,FFR值降低(P<0.05)。多因素Logistic回归分析显示,KILLIP分级≥Ⅲ级、CysC升高、CT-1升高为影响冠状动脉中度狭窄冠心病患者PCI术后MACE发生的独立危险因素,左室射血分数升高和FFR值升高为独立保护因素(P<0.05)。ROC曲线分析显示,血清CysC、CT-1联合FFR值预测冠状动脉中度狭窄冠心病患者PCI术后MACE发生风险的曲线下面积为0.906,大于血清CysC、CT-1、FFR值单独预测的0.771、0.775、0.797。结论:血清CysC、CT-1水平升高和FFR值降低与冠状动脉中度狭窄冠心病患者PCI术后MACE发生密切相关,血清CysC、CT-1联合FFR值预测冠状动脉中度狭窄冠心病患者PCI术后MACE发生风险的价值较高。 |
英文摘要: |
ABSTRACT Objective: To investigate the predictive value of serum cystatin C (CysC), cardiotrophin-1 (CT-1) combined with coronary fractional flow reserve (FFR) in predicting the risk of major adverse cardiac events (MACE) after percutaneous coronary intervention (PCI) in patients with coronary heart disease with moderate coronary artery stenosis. Methods: 260 patients with coronary heart disease with moderate coronary artery stenosis who were admitted to Nanjing Drum Tower Hospital from January 2020 to March 2022 were selected, patients were divided into MACE group (n=36) and non-MACE group (n=224) according to whether MACE occurred 1 year after PCI. Serum CysC and CT-1 levels were detected and FFR values were calculated. The risk factors affecting the occurrence of MACE after PCI in patients with coronary heart disease with moderate coronary artery stenosis were analyzed by constructed multivariate Logistic regression model, the predictive value of serum CysC, CT-1 combined with FFR value for the risk of MACE after PCI in patients with coronary heart disease with moderate coronary artery stenosis were analyzed by receiver operating characteristic(ROC) curve. Results: After 1 year of follow-up, there was no loss of follow-up, and the incidence of MACE after PCI in 260 patients with moderate coronary artery stenosis was 13.85% (36/260). Compared with non-MACE group, the levels of serum CysC and CT-1 in MACE group increased, and the FFR value decreased(P<0.05). Multivariate Logistic regression analysis showed that, KILLIP grade≥III, elevated CysC and elevated CT-1 were independent risk factors for MACE after PCI in patients with coronary heart disease with moderate coronary artery stenosis, and elevated left ventricular ejection fraction and elevated FFR were independent protective factors (P<0.05). ROC curve analysis showed that, the area under the curve of serum CysC, CT-1 combined with FFR in predicting the risk of MACE after PCI in patients with moderate coronary artery stenosis was 0.906, which was greater than 0.771, 0.775 and 0.797 predicted by serum CysC, CT-1 and FFR alone. Conclusion: The increase of serum CysC and CT-1 levels and the decrease of FFR value are closely relate to the occurrence of MACE after PCI in patients with moderate coronary artery stenosis, the value of serum CysC and CT-1 combine with FFR value in predicting the risk of MACE after PCI in patients with moderate coronary artery stenosis is higher. |
View Full Text
View/Add Comment Download reader |
Close |